Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 43: 2169-2174, 1997;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D'Angelo, A.
Right arrow Articles by Tests, H. L. o. b. o. t. I. W. G. S. o. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D'Angelo, A.
Right arrow Articles by Tests, H. L. o. b. o. t. I. W. G. S. o. C.
(Clinical Chemistry. 1997;43:2169-2174.)
© 1997 American Association for Clinical Chemistry, Inc.

Articles

Comparison of mean normal prothrombin time (PT) with PT of fresh normal pooled plasma or of a lyophilized control plasma (R82A) as denominator to express PT results: collaborative study of the International Federation of Clinical Chemistry

Armando D'Angelo1,a, Laura Galli2 and Hartmut Lang on behalf of the IFCC Working Group Standardization of Coagulation Tests3,4

1 Coagulation Service and
2 Department of Epidemiology, Scientific Institute H S. Raffaele, Milano, Italy.

3 Immuno AG, Vienna, Austria.

4 List of participants (in alphabetical order): J. Amiral, Gennevilliers, France; H. Beeser, Freiburg i.B., Germany; P. J. Braun, Durham, NC; P. C. Comp, Oklahoma City, OK; A. D'Angelo, Milano, Italy; F. Dati, Marburg, Germany; A. Duncan, Atlanta, GA; A. Girolami, Padova, Italy; F. Keller, Würzburg, Germany; H. Lang, Vienna, Austria; M. M. Müller, Vienna, Austria; H. Pelzer, Miami, FL; P. Sie, Toulouse, France; D. A. Triplett, Muncie, IN; J. W. J. van Wersch, Heerlen, The Netherlands.
a Author for correspondence. Servizio di Coagulazione, Istituto Scientifico H S. Raffaele, Via Olgettina 60, 20132 Milano Italy. Fax 39-2-26432640.

The mean normal prothrombin time (MNPT) is currently recommended as the denominator term in the expression of PT ratio or International Normalized Ratio (INR) values. The PT of lyophilized normal control plasmas might also be used in calculating PT ratios, but the overall accuracy of this approach and its dependence on reagents and endpoint detectors have not been evaluated in detail. In an IFCC collaborative study involving 15 expert laboratories and 58 PT systems, the PT ratios of 30 apparently healthy subjects were expressed with the use of the MNPT, the PT of fresh normal pooled plasma (FNPP) obtained from the same apparently healthy subjects, or the PT of plasma R82A—a lyophilized normal pooled plasma prepared by the Verband der Deutschen Geräte-Hersteller for in-house calibration of a large amount of control plasma—as the denominator term. The total imprecision of the PT of plasma R82A averaged 2.16%. Mean PT ratios did not differ from 1.00 (mean 1.00, range 1.00–1.01) with the use of the MNPT as the denominator term. Mean PT ratios were >1.00 with the FNPP-PT as the denominator term (1.02, 0.96–1.05), and differed according to endpoint detectors (P = 0.024). Mean PT ratios with plasma R82A-PT as the denominator term averaged 0.98 (range 0.91–1.06) with plain thromboplastins (n = 11), 1.02 (0.98–1.06) with combined thromboplastins (n = 3), and 0.93 (0.87–0.97) with recombinant thromboplastins (n = 2), but they differed according to the brand of plain or recombinant reagents (P = 0.00001), the endpoint detector (P <0.0025), and the plasma citrate concentration (P <0.0025). These findings underline the differences in the PT of lyophilized plasma R82A and the MNPT and PT of FNPP obtained from the same individuals and support the recommendation that the system-specific MNPT should be used as the ideal index of the normal PT in the calculation of INR values.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
A. M.H.P. van den Besselaar and W. P.M. Houdijk
Use of Lyophilized Calibrant Plasmas for Simplified International Normalized Ratio Determination with a Human Tissue Factor Thromboplastin Reagent Derived from Cultured Human Cells
Clin. Chem., December 1, 2003; 49(12): 2006 - 2011.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. J. Hursting, J. L. Zehnder, J. L. Joffrion, J.-C. Becker, G. D. Knappenberger, and R. P. Schwarz Jr.
The International Normalized Ratio during Concurrent Warfarin and Argatroban Anticoagulation: Differential Contributions of Each Agent and Effects of the Choice of Thromboplastin Used
Clin. Chem., March 1, 1999; 45(3): 409 - 412.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.